Impact of HIV Status Notification on Risk Behaviors among Men Who Inject Drugs in Kermanshah, West of Iran
暂无分享,去创建一个
M. Noroozi | A. Mirzazadeh | H. Khankeh | A. Noroozi | H. Sharifi | B. Armoon | A. Farhoudian | P. Higgs | A. Hajebi | Bahram Armoon
[1] M. Noroozi,et al. Comparing profile of people who inject drugs (PWID) accessing different types of needle and syringe programs or secondary distribution in Kermanshah, Iran , 2017 .
[2] M. Noroozi,et al. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran. , 2016, The International journal on drug policy.
[3] M. Noroozi,et al. Client-Level Coverage of Needle and Syringe Program and High-Risk Injection Behaviors: A Case Study of People Who Inject Drugs in Kermanshah, Iran , 2015, Addiction & health.
[4] J. Pope,et al. Extending coarsened exact matching to multiple cohorts: an application to longitudinal well-being program evaluation within an employer population , 2015, Health Services and Outcomes Research Methodology.
[5] Hongyun Fu,et al. Do community-based strategies reduce HIV risk among people who inject drugs in China? A quasi-experimental study in Yunnan and Guangxi provinces , 2014, Harm Reduction Journal.
[6] R. Bluthenthal,et al. Characteristics of people who initiate injection drug use later in life. , 2014, Drug and alcohol dependence.
[7] M. Abrahamowicz,et al. Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] M. Hellard,et al. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study. , 2014, The International journal on drug policy.
[9] Michael W. Spiller,et al. Prevalence of HIV Infection and Risk Behaviors Among Younger and Older Injecting Drug Users in the United States, 2009 , 2014, AIDS and Behavior.
[10] S. Lenton,et al. The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs. , 2013, Drug and alcohol dependence.
[11] A. Haghdoost,et al. HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey , 2013, Sexually Transmitted Infections.
[12] M. Brandeau,et al. Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users , 2012, PloS one.
[13] A. Haghdoost,et al. Modeling of human immunodeficiency virus modes of transmission in Iran. , 2012, Journal of research in health sciences.
[14] A. Rahimi-Movaghar,et al. HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007. , 2012, The International journal on drug policy.
[15] R. Majdzadeh,et al. What are Differences between Non-injecting and Injecting Drug Addicts? , 2012, International journal of preventive medicine.
[16] A. Mirzazadeh,et al. Modelling of HIV / AIDS in Iran up to 2014 , 2012 .
[17] M. Schechter,et al. The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people , 2011, Canadian Medical Association Journal.
[18] Elizabeth A Stuart,et al. Matching methods for causal inference: A review and a look forward. , 2010, Statistical science : a review journal of the Institute of Mathematical Statistics.
[19] E. Vittinghoff,et al. Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco. , 2009, Drug and alcohol dependence.
[20] M. Forouzanfar,et al. Prevalence of HIV and Hepatitis C Virus Infections and Related Behavioral Determinants among Injecting Drug Users of Drop-in Centers in Iran , 2009 .
[21] M Mofizul Islam,et al. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings. , 2008, The International journal on drug policy.
[22] Linda Richter,et al. Behavioural strategies to reduce HIV transmission: how to make them work better , 2008, The Lancet.
[23] B. Eshrati,et al. Preventing HIV transmission among Iranian prisoners: Initial support for providing education on the benefits of harm reduction practices , 2008, Harm reduction journal.
[24] C. Watts,et al. A systematic review of published evidence on intervention impact on condom use in sub-Saharan Africa and Asia , 2007, Sexually Transmitted Infections.
[25] C. Watts,et al. Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India , 2007, BMC Public Health.
[26] H. Klee,et al. Hepatitis C testing and injecting risk behaviour: the results of a UK based pilot study , 2004 .
[27] J. Coste,et al. HCV status knowledge and risk behaviours amongst intravenous drug users , 2000, European Journal of Epidemiology.
[28] D. Vlahov,et al. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] N. Crofts,et al. Peer-delivered hepatitis C testing and counselling: a means of improving the health of injecting drug users. , 2002, Drug and alcohol review.
[30] M. Mccusker. Influence of hepatitis C status on alcohol consumption in opiate users in treatment. , 2001, Addiction.